文献速递瓣膜外科

高危和极高危重度主动脉瓣狭窄患者经导管主动脉瓣置换术后再入院率研究

Readmission rates after transcatheter aortic valve replacement in high- and extreme-risk patients with severe aortic stenosis.
PubMed 文献 · J Thorac Cardiovasc Surg · 2017-04-18

该回顾性研究纳入2007年9月至2015年1月在埃默里大学接受经导管主动脉瓣置换的714例高危或极高危重度主动脉瓣狭窄患者,分析30天和1年心脏与非心脏再入院的发生率、预测因素及其与1年死亡率的关系。结果显示早期全因再入院率为10.5%,晚期为18.8%,贫血和术后卒中与再入院及死亡率增加相关,再入院与1年死亡风险翻倍相关。

要点

  • 高危和极高危患者TAVR术后30天全因再入院率10.5%,晚期再入院率18.8%。
  • 贫血与早期全因及心血管相关再入院相关,术后永久性卒中与晚期心血管相关再入院相关。
  • 再入院与1年死亡率相关,风险比为2.04(95%CI 1.33-3.12)。

核心结论

  • 部分基线合并症和手术并发症与早期和晚期再入院直接相关,贫血和术后卒中与死亡率增加相关。
  • 再入院与1年内死亡风险翻倍相关。
  • 治疗已识别的危险因素能否降低再入院率和死亡率尚需进一步研究。

研究设计与样本

  • 回顾性研究,纳入2007年9月至2015年1月在埃默里大学接受经导管主动脉瓣置换的714例高危或极高危重度主动脉瓣狭窄患者。
  • 患者中位年龄83岁,46.6%为女性。

主要发现

  • 早期全因再入院率为10.5%,晚期再入院率为18.8%。
  • 贫血与早期全因再入院(HR 0.74)和心血管相关再入院(HR 0.60)相关。
  • 植入23-mm瓣膜与早期全因再入院相关(HR 1.73)。
  • 住院时间与晚期全因再入院(HR 1.14)和心血管相关再入院(HR 1.21)相关。
  • 术后永久性卒中影响晚期心血管相关再入院(HR 3.60;95%CI 1.13-11.49)。

临床怎么用

  • 对TAVR术后高危患者应关注贫血和术后卒中等危险因素,以识别再入院高风险人群。
  • 再入院与1年死亡风险翻倍相关,提示再入院可作为预后评估的参考事件。

局限性

  • 原文未明确报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In high- or extreme-risk patients undergoing transcatheter aortic valve replacement, readmissions have not been adequately studied and are the subject of increased scrutiny by healthcare systems. The objectives of this study were to determine the incidence of 30-day and 1-year cardiac and noncardiac readmissions, identify predictors of readmission, and assess the association between readmission and 1-year mortality. METHODS: A retrospective review was performed on 714 patients who underwent transcatheter aortic valve replacement from September 2007 to January 2015 at Emory University. RESULTS: Patients' median age was 83 years, and 46.6% were female. Early all-cause readmission for the cohort was 10.5%, and late readmission was 18.8%. Anemia was related to both early all-cause (hazard ratio [HR], 0.74) and cardiovascular-related readmission (HR, 0.60). A 23-mm valve implanted was associated with early all-cause readmission (HR, 1.73). Length of hospital stay was related to late all-cause (HR, 1.14) and cardiovascular-related readmission (HR, 1.21). Postoperative permanent stroke had an impact on late cardiovascular-related readmission (HR, 3.60; 95% confidence interval, 1.13-11.49). Multivariable analysis identified anemia as being associated with 30-day all-cause readmission, and anemia and postoperative stroke were associated with 30-day cardiovascular-related readmission. Readmissions seemed to be related to 1-year mortality (HR, 2.04; 95% confidence interval, 1.33-3.12). CONCLUSIONS: We show some baseline comorbidities and procedural complications that are directly associated with early and late readmissions, and anemia and postoperative stroke were associated with an increase in mortality. Moreover, we found that readmission was associated with double the hazard of death within 1 year. Whether treatment of identified risk factors could decrease readmission rates and mortality warrants further investigation.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Forcillo J, Condado JF, Binongo JN, et al. Readmission rates after transcatheter aortic valve replacement in high- and extreme-risk patients with severe aortic stenosis. J Thorac Cardiovasc Surg. 2017. PMID: 28532575. doi:10.1016/j.jtcvs.2017.03.144

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。